 | Nanotechnology Methods for Neurological Diseases and Brain Tumors Nanotechnology Methods for Neurological Diseases and Brain Tumors: Drug Delivery across the Blood-Brain Barrier compiles the latest (and future potential) treatment strategies for brain tumors and neurological diseases, in particular Alzheimer's, Parkinson's and stroke, those that bypass the blood/brain barrier. The current understanding of brain drug delivery and access is discussed in Chapter One, with the next section focusing on the implementation of the nose-to-brain intranasal route in brain-targeted drug delivery. In addition, nanotechnology-based brain drug delivery is covered in Chapter Three. This avenue offers impressive improvement in the treatment of neurological diseases and brain tumors by using bio-engineered systems that interact with biological systems at a molecular level. In Chapter Four, emphasis is placed on the need for brain-targeted experimental models that mimic disease conditions. Final chapters discuss the very latest advances in targeted treatment strategies for neurological diseases and brain tumors. Yasemin G#65533;rsoy #65533;zdemir (M.D., Ph.D.) is a Professor of Neurology and Neuroscience at Ko#65533; University, School of Medicine in Istanbul, Turkey. Dr. G#65533;rsoy #65533;zdemir's main research interests are basic pathophysiological aspects of neurological diseases, especially migraine, headache, stroke, neurodegenerative diseases and their translation to clinical neurology. She conducted several experimental studies about blood brain barrier changes during neurological diseases and targeted drug delivery strategies. She is the author of several research articles published in peer-reviewed indexed journals. She did her post-doctoral studies at Mass General Hospital, Harvard University, Boston. She was associate director of Hacettepe University Institute of Neurological Sciences and Psychiatry between 2011-2014. She gave numerous lectures at both Faculty of Medicine during Neurology board and Institute of Neurological Sciences and Psychiatry at PhD programs. She received several awards such as Research Encouragement Award of Brain Research Organization, Young Researcher Awards of Hacettepe University, Turkish Academy of Sciences and Young Investigator Award from The Scientific and Technological Council of Turkey (TUBITAK). Dr. Bozdag Pehlivan is an Associate Professor at Hacettepe University, Faculty of Pharmacy Pharmaceutical Technology Department in Ankara, Turkey. Her research interests are design and in vitro/in vivo evaluation of nanotechnology-based drug delivery systems, targeted drug delivery for brain tumors, and ocular drug delivery. She is author of several research articles published in peer-reviewed indexed journals on the topic. She is a member of American Association of Pharmaceutical Scientists. She received several awards such as the Hacettepe University Research Group Award and Awards in the Hacettepe Technopolis Innovation Competition: Health Sciences and Technologies category (2008 and 2009). Emine Sekerdag (MSc.), earned both her Bachelor of Science degree and Master of Science degree of Bio-Pharmaceutical Sciences at Leiden University in The Netherlands. She performed the first part of her Master study at the Drug Delivery Technology department of the Leiden Academic Center for Drug Research (LACDR) at Leiden University, where she worked on transdermal drug delivery with vaccine coated solid microneedles for which she developed a coating procedure. She also obtained in vitro/in vivo experience in this field, and drug delivery technologies became one of her passions. She completed the last part of her Master at the Pharmaceutical Technology department of Hacettepe University in Ankara, Turkey, working with hybrid nanoparticles for brain targeted nasal drug delivery. Currently, she is a PhD candidate at the Neuroscience Department of Ko? University, working with targeted treatment strategies for neurological disorders. |
